The Aster DM Healthcare IPO date has been confirmed from February 12, 2018 and ended on February 15, 2018.
Using an IPO, Aster DM Healthcare is seeking to raise Rs 980.14 crores. Its price band is set at ₹180 to ₹190 per share. The minimum lot size for an application is 78 Shares. The minimum amount of investment required by retail investors is ₹14,820.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
February 12-15
Price Range
₹180 to ₹190 per share
Face Value
₹10 per share
GMP
₹395.40
Aster DM Healthcare IPO GMP
The Aster DM Healthcare Limited IPO GMP is ₹395.40.
IPO Overview
The Aster DM Healthcare IPO is a book-built offering for Rs 980.14 crores. The offering consists of a fresh issue of Rs 725.00 crore and an offer to sell 1.34 crore shares. Bidding for the Aster DM Healthcare IPO began on February 12, 2018 and finished on February 15, 2018. On Thursday, February 22, 2018, the allotment for the Aster DM Healthcare IPO was completed. On February 26, 2018, the shares were listed on the BSE and NSE. The price range for Aster DM Healthcare’s IPO is set at 180 to 190 per share.
Aster operates hospitals in Kochi, Kolhapur, Kozhikode, Kottakkal, Bengaluru, Vijayawada, Guntur, Wayanad, and Hyderabad under the Aster, MIMS, Ramesh, and Prime brands. An application requires a minimum lot size of 78 Shares. Retail investors must make a minimum investment of ₹14,820.
Aster DM Healthcare IPO Details
IPO Date | February 12, 2018 to February 15, 2018 |
Listing Date | February 26, 2018 |
Face Value | ₹10 per share |
Price Band | ₹180 to ₹190 per share |
Lot Size | 78 Shares |
Total Issue Size | [.] shares (aggregating up to ₹980.14 Cr) |
Fresh Issue | [.] shares (aggregating up to ₹725.00 Cr) |
Offer for Sale | 13,428,251 shares of ₹10 (aggregating up to ₹[.] Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Aster DM Healthcare Company Financials
Particulars | For the year/period ended (in Rs. million) | |||||
---|---|---|---|---|---|---|
31-Mar-17 | 31-Mar-16 | 31-Mar-15 (Proforma) | ||||
Total Assets | 68,072.77 | 57,557.82 | 44,120.27 | |||
Total Revenue | 59,679.02 | 52,751.63 | 38,990.49 | |||
Profit After Tax | 2,667.47 | 82.11 | 2,721.07 |
Aster DM Healthcare IPO Timeline
IPO Open Date | Monday, February 12, 2018 |
IPO Close Date | Thursday, February 15, 2018 |
Basis of Allotment | Thursday, February 22, 2018 |
Initiation of Refunds | Thursday, February 22, 2018 |
Credit of Shares to Demat | Friday, February 23, 2018 |
Listing Date | Monday, February 26, 2018 |
Cut-off time for UPI mandate confirmation | 5 PM on February 15, 2018 |
Company Profile
Aster DM Healthcare Ltd, founded in 1987 in Kochi, Kerala, is a healthcare service company with operations in the GCC (United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait, and Bahrain), India, and the Philippines. The Indian operations of the company are headquartered in Kochi, Kerala. Aster DM Healthcare engages in a variety of healthcare industries, including hospitals, clinics, and retail pharmacies. The company owns and runs hospitals and clinics, pharmacies, diagnostic centres, educational institutions, as well as healthcare management and support
systems. Under brand names such as “Aster,” “Medcare,” and “Access,” the company delivers healthcare services to patients across economic groups. As of September 30, 2017, Aster’s healthcare facilities included 9 hospitals, 90 clinics, and 206 retail pharmacies across the GCC states, 10 multi-specialty hospitals and 7 clinics in India, and 1 clinic in the Philippines. As of September 30, 2017, Aster’s had 17,408 employees, including 1,417 full-time doctors, 5,797 nurses, 1,752 paramedics, and 8,442 other personnel (including pharmacists).
Registrar Info
Name | Link Intime India Private Ltd |
Phone number | +91-22-4918 6270 |
Email ID | adhl.ipo@linkintime.co.in |
Website | linkintime.co.in |
Contact Details
Name | Aster DM Healthcare Ltd |
Phone number | + 91 484 6699 228 |
Email ID | investors@asterdmhealthcare.com |
Website | asterdmhealthcare.com |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.